GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: Modeyso® | ONC-201 | ONC201 | TIC-10 | TIC10
                                 
                                                         
                            
                            
                            
                                 
                                
                                dordaviprone is an approved drug 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Dordaviprone (ONC201, also known as TIC10 [2]) was originally discovered as a TRAIL pathway inducer and as an orally active dual Akt/ERK inhibitor [1]. It exerts potent anti-tumour effects [6,10-11]. 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                    ONC201 was later reported as an allosteric activator of the oncology drug target, mitochondrial protease caseinolytic protease P (ClpP) [4-5,9]. It also antagonises dopamine D2/3 receptor signalling [7-8].  | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. US FDA (2025) | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 12147 | dordaviprone | 
Synonyms ![]()  | 
                                                        
| Modeyso® | ONC-201 | ONC201 | TIC-10 | TIC10 | 
Database Links ![]()  | 
                                                        |
| BindingDB Ligand | 50606048 | 
| CAS Registry No. | 1616632-77-9 (source: WHO INN record) | 
| ChEMBL Ligand | CHEMBL4297310 | 
| DrugBank Ligand | DB14844 | 
| GtoPdb PubChem SID | 374883865 | 
| PubChem CID | 73777259 | 
| Search Google for chemical match using the InChIKey | VLULRUCCHYVXOH-UHFFFAOYSA-N | 
| Search Google for chemicals with the same backbone | VLULRUCCHYVXOH | 
| Search PubMed clinical trials | dordaviprone | 
| Search PubMed titles | dordaviprone | 
| Search PubMed titles/abstracts | dordaviprone | 
| UniChem Compound Search for chemical match using the InChIKey | VLULRUCCHYVXOH-UHFFFAOYSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | VLULRUCCHYVXOH-UHFFFAOYSA-N |